By Professor Simon Finfer

Journal articles

Rudd KE; Johnson SC; Agesa KM; Shackelford KA; Tsoi D; Kievlan DR; Colombara DV; Ikuta KS; Kissoon N; Finfer S; Fleischmann-Struzek C; Machado FR; Reinhart KK; Rowan K; Seymour CW; Watson RS; West TE; Marinho F; Hay SI; Lozano R; Lopez AD; Angus DC; Murray CJL; Naghavi M, 2020, 'Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study', The Lancet, 395, pp. 200 - 211, http://dx.doi.org/10.1016/S0140-6736(19)32989-7

Young P; Mackle D; Bellomo R; Bailey M; Beasley R; Deane A; Eastwood G; Finfer S; Freebairn R; King V; Linke N; Litton E; McArthur C; McGuinness S; Panwar R, 2020, 'Conservative oxygen therapy for mechanically ventilated adults with sepsis: a post hoc analysis of data from the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX)', Intensive Care Medicine, 46, pp. 17 - 26, http://dx.doi.org/10.1007/s00134-019-05857-x

Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Glass P; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J, 2019, 'Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion Criteria: A Post Hoc Analysis of the ADRENAL Trial', Anesthesiology, 131, pp. 1292 - 1300, http://dx.doi.org/10.1097/ALN.0000000000002955

Hammond NE; Bellomo R; Gallagher M; Gattas D; Glass P; Mackle D; Micallef S; Myburgh J; Saxena M; Taylor C; Young P; Finfer S, 2019, 'The Plasma-Lyte 148 versus Saline (PLUS) study protocol amendment', Critical Care and Resuscitation, 21, pp. 284 - 286

Schlapbach LJ; Thompson K; Finfer SR, 2019, 'The WHO resolution on sepsis: what action is needed in Australia?', Medical Journal of Australia, 211, pp. 395 - 397.e1, http://dx.doi.org/10.5694/mja2.50279

Prescott HC; Iwashyna TJ; Blackwood B; Calandra T; Chlan LL; Choong K; Connolly B; Dark P; Ferrucci L; Finfer S; Girard TD; Hodgson C; Hopkins RO; Hough CL; Jackson JC; Machado FR; Marshall JC; Misak C; Needham DM; Panigrahi P; Reinhart K; Yende S; Zafonte R; Rowan KM; Angus DC, 2019, 'Understanding and enhancing sepsis survivorship priorities for research and practice', American Journal of Respiratory and Critical Care Medicine, 200, pp. 972 - 981, http://dx.doi.org/10.1164/rccm.201812-2383CP

Poole AP; Anstey J; Bellomo R; Biradar V; Deane AM; Finfer SR; Finnis ME; French CJ; Kar P; Kruger PS; Maiden MJ; Mårtensson J; McArthur CJ; McGuinness SP; Secombe PJ; Tobin AE; Udy AA; Eastwood GM, 2019, 'Opinions and practices of blood glucose control in critically ill patients with pre-existing type 2 diabetes in Australian and New Zealand intensive care units', Australian Critical Care, 32, pp. 361 - 365, http://dx.doi.org/10.1016/j.aucc.2018.09.001

Elliott CG; Orme J; Weaver LK, 2019, 'Pneumatic Compression in Venous Thromboprophylaxis.', N Engl J Med, 381, pp. 94, http://dx.doi.org/10.1056/NEJMc1905933

Napolitano LM, 2019, 'Pneumatic Compression in Venous Thromboprophylaxis.', N Engl J Med, 381, pp. 94 - 95, http://dx.doi.org/10.1056/NEJMc1905933

Arabi YM; Burns KEA; Finfer S, 2019, 'Pneumatic Compression in Venous Thromboprophylaxis. Reply', The New England journal of medicine, 381, pp. 95, http://dx.doi.org/10.1056/NEJMc1905933

Andersen CR; Fitzgerald E; Delaney A; Finfer S, 2019, 'A Systematic Review of Outcome Measures Employed in Aneurysmal Subarachnoid Hemorrhage (aSAH) Clinical Research', Neurocritical Care, 30, pp. 534 - 541, http://dx.doi.org/10.1007/s12028-018-0566-0

Arabi YM; Al-Hameed F; Burns KEA; Mehta S; Alsolamy SJ; Alshahrani MS; Mandourah Y; Almekhlafi GA; Almaani M; Al Bshabshe A; Finfer S; Arshad Z; Khalid I; Mehta Y; Gaur A; Hawa H; Buscher H; Lababidi H; Al Aithan A; Abdukahil SAI; Jose J; Afesh LY; Al-Dawood A, 2019, 'Adjunctive intermittent pneumatic compression for venous thromboprophylaxis', New England Journal of Medicine, 380, pp. 1305 - 1315, http://dx.doi.org/10.1056/NEJMoa1816150

Huang CY; Daniels R; Lembo A; Hartog C; O’Brien J; Heymann T; Reinhart K; Nguyen HB; Azevedo L; Finfer S; Fleischmann C; Foreman T; Kissoon N; Machado F; Martens C; Possagnoli I; Hanke R; Vroomen-Durning M, 2019, 'Life after sepsis: An international survey of survivors to understand the post-sepsis syndrome', International Journal for Quality in Health Care, 31, pp. 191 - 198, http://dx.doi.org/10.1093/intqhc/mzy137

Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM, 2019, 'A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III', Critical Care and Resuscitation, 21, pp. 63 - 68

Thompson K; Venkatesh B; Finfer S, 2019, 'Sepsis and septic shock: current approaches to management', Internal Medicine Journal, 49, pp. 160 - 170, http://dx.doi.org/10.1111/imj.14199

O'Brien Z; Cass A; Cole L; Finfer S; Gallagher M; McArthur C; McGuiness S; Myburgh J; Bellomo R; Mårtensson J, 2019, 'Sex and mortality in septic severe acute kidney injury', Journal of Critical Care, 49, pp. 70 - 76, http://dx.doi.org/10.1016/j.jcrc.2018.10.017

Perner A; Finfer S, 2018, 'Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? Yes', Intensive Care Medicine, 44, pp. 1985 - 1988, http://dx.doi.org/10.1007/s00134-018-5129-5

Finfer S; Myburgh J; Bellomo R, 2018, 'Erratum to: Intravenous fluid therapy in critically ill adults (Nature Reviews Nephrology, (2018), 14, 9, (541-557), 10.1038/s41581-018-0044-0)', Nature Reviews Nephrology, 14, pp. 717, http://dx.doi.org/10.1038/s41581-018-0060-0

Gårdlund B; Dmitrieva NO; Pieper CF; Finfer S; Marshall JC; Taylor Thompson B, 2018, 'Six subphenotypes in septic shock: Latent class analysis of the PROWESS Shock study', Journal of Critical Care, 47, pp. 70 - 79, http://dx.doi.org/10.1016/j.jcrc.2018.06.012

Heldens M; Schout M; Hammond NE; Bass F; Delaney A; Finfer SR, 2018, 'Sepsis incidence and mortality are underestimated in Australian intensive care unit administrative data', Medical Journal of Australia, 209, pp. 255 - 260, http://dx.doi.org/10.5694/mja18.00168

Venkatesh B; Mehta S; Angus DC; Finfer S; Machado FR; Marshall J; Mitchell I; Peake S; Zimmerman JL, 2018, 'Women in Intensive Care study: A preliminary assessment of international data on female representation in the ICU physician workforce, leadership and academic positions', Critical Care, 22, http://dx.doi.org/10.1186/s13054-018-2139-1

Finfer S; Myburgh J; Bellomo R, 2018, 'Intravenous fluid therapy in critically ill adults', Nature Reviews Nephrology, 14, pp. 541 - 557, http://dx.doi.org/10.1038/s41581-018-0044-0

Venkatesh B; Finfer S; Myburgh J, 2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock Reply', NEW ENGLAND JOURNAL OF MEDICINE, 379, pp. 895 - 895, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443047800023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Simpson SQ, 2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 894, http://dx.doi.org/10.1056/NEJMc1804993

Gunst J; Van den Berghe G, 2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 894, http://dx.doi.org/10.1056/NEJMc1804993

Annane D; Renault A; Bellissant E, 2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 895 - 896, http://dx.doi.org/10.1056/NEJMc1804993

Arafah BM, 2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 894 - 895, http://dx.doi.org/10.1056/NEJMc1804993

Schlegel A, 2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 893, http://dx.doi.org/10.1056/NEJMc1804993

Scheer CS, 2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 893 - 894, http://dx.doi.org/10.1056/NEJMc1804993

Thompson K; Taylor C; Jan S; Li Q; Hammond N; Myburgh J; Saxena M; Venkatesh B; Finfer S, 2018, 'Health-related outcomes of critically ill patients with and without sepsis', Intensive Care Medicine, 44, pp. 1249 - 1257, http://dx.doi.org/10.1007/s00134-018-5274-x

Roberts I; Shakur H; Bellomo R; Bion J; Finfer S; Hunt B; Myburgh J; Perner A; Reinhart K, 2018, 'Should hydroxyethyl starch be banned? – Authors' reply', The Lancet, 392, pp. 119, http://dx.doi.org/10.1016/S0140-6736(18)31179-6

Rygård SL; Butler E; Granholm A; Møller MH; Cohen J; Finfer S; Perner A; Myburgh J; Venkatesh B; Delaney A, 2018, 'Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis', Intensive Care Medicine, 44, pp. 1003 - 1016, http://dx.doi.org/10.1007/s00134-018-5197-6

Wang Y; Gallagher M; Li Q; Lo S; Cass A; Finfer S; Myburgh J; Bouman C; Faulhaber-Walter R; Kellum JA; Palevsky PM; Ronco C; Saudan P; Tolwani A; Bellomo R, 2018, 'Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: A systematic review and individual patient data meta-analysis', Nephrology Dialysis Transplantation, 33, pp. 1017 - 1024, http://dx.doi.org/10.1093/ndt/gfx308

Venkatesh B; Finfer S; Myburgh J; Cohen J; Billot L, 2018, 'Long-Term outcomes of the ADRENAL trial', New England Journal of Medicine, 378, pp. 1744 - 1745, http://dx.doi.org/10.1056/NEJMc1803563

Aubron C; Kandane-Rathnayake RK; Andrianopoulos N; Westbrook A; Engelbrecht S; Ozolins I; Bailey M; Murray L; Cooper DJ; Wood EM; McQuilten ZK; Pettilä V; Nichol A; Phillips LE; Street A; French C; Orford N; Santamaria J; Bellomo R; Vallance S; McArthur C; McGuiness S; Newby L; Simmonds C; Parke R; Buhr H; Goldsmith D; O'Sullivan K; Mercer I; Gazzard R; Tauschke C; Hill D; Fletcher J; Boschert C; Koch G; Ernest D; Eliott S; Howe B; Hawker F; Ellem K; Duff K; Henderson S; Mehrtens J; Milliss D; O'Bree B; Shepherd K; Ihle B; Ho S; Graan M; Bernsten A; Ryan E; Botha J; Vuat J; Kinmonth A; Fraser M; Richards B; Tallott M; Whitbread R; Freebairn R; Thomas L; Parr M; Micallef S; Deshpande K; Wood J; Williams T; Tai J; Boase A; Galt P; King B; Price R; Tomlinson J; Cole L; Seppelt I; Weisbrodt L; Gresham R; Nikas M; Laing J; Bell J; McHugh G; Hancock D; Kirkham S; Shehabi Y; Campbell M; Stockdale V; Peake S; Williams P; Sharley P; O'Connor S; Stephens D; Thomas J; Sistla R; McAllister R; Marsden K; MacIsaac C; Barge D; Caf T; Finfer S; Tan L; Bird S; Webb S, 2018, 'Day or overnight transfusion in critically ill patients: does it matter?', Vox Sanguinis, 113, pp. 275 - 282, http://dx.doi.org/10.1111/vox.12635

O'Brien Z; Cass A; Cole L; Finfer S; Gallagher M; McArthur C; McGuiness S; Myburgh J; Bellomo R; Mårtensson J, 2018, 'Higher versus Lower Continuous Renal Replacement Therapy Intensity in Critically ill Patients with Liver Dysfunction', Blood Purification, 45, pp. 36 - 43, http://dx.doi.org/10.1159/000480224

Frankling CC; Finfer S; Lissauer D; Perner A; Patel JM; Gao F, 2018, 'The dark ages of maternal sepsis: time to be enlightened', British Journal of Anaesthesia, 120, pp. 626 - 628, http://dx.doi.org/10.1016/j.bja.2017.12.032

Arabi Y; Al-Hameed F; Burns KEA; Mehta S; Alsolamy S; Almaani M; Mandourah Y; Almekhlafi GA; Al Bshabshe A; Finfer S; Alshahrani M; Khalid I; Mehta Y; Gaur A; Hawa H; Buscher H; Arshad Z; Lababidi H; Al Aithan A; Jose J; Abdukahil SAI; Afesh LY; Dbsawy M; Al-Dawood A; Rowan K; Thabane L; Garcia DA; Hegazy M; Rasool G; Rifai J; Mohamed AS; Orabi OA; Sufiani DA; Amodi EA; Alkhader M; Awad S; Cabal MRC; Valerio JS; Hassan S; Alanazi B; Alharbi K; Alenazy A; Asonto LP; Loyola KLD; Albahar A; Alamri A; Bashir S; Abdulmuthalib H; Ntinika P; Pangilinan R; Jadkareem A; Bawazeer E; Bassi S; Qushmaq I; Maghrabi K; Hijazi M; Abdelhai M; Pagunsan EJ; Vinklerova M; Shah S; Tamberg E; Smith O; Santos M; Sandhu G; Hodder J; Salway K; Jacka M; McCoshen L; Baig N; Ellis K; White M; Gregory R; Cameron R; O'Connor A; Yarad E; Bass F; Hammond N; Reynolds C; McCann K; Srivastava SK; Singh A; George J; Mehta C; Kumar A, 2018, 'Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: A study protocol for a randomized controlled trial', Trials, 19, pp. 182, http://dx.doi.org/10.1186/s13063-018-2534-6

Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Correa M; Glass P; Harward M; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J; Saxena M, 2018, 'Adjunctive glucocorticoid therapy in patients with septic shock', New England Journal of Medicine, 378, pp. 797 - 808, http://dx.doi.org/10.1056/NEJMoa1705835

Mackle DM; Bailey MJ; Beasley RW; Bellomo R; Bennett VL; Deane AM; Eastwood GM; Finfer S; Freebairn RC; Litton E; Linke NJ; McArthur CJ; McGuinness SP; Panwar R; Young PJ, 2018, 'Protocol summary and statistical analysis plan for the intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX)', Critical Care and Resuscitation, 20, pp. 22 - 32

Roberts I; Shakur H; Bellomo R; Bion J; Finfer S; Hunt B; Myburgh J; Perner A; Reinhart K, 2018, 'Hydroxyethyl starch solutions and patient harm', The Lancet, 391, pp. 736, http://dx.doi.org/10.1016/S0140-6736(18)30255-1

Alhazzani W; Alshamsi F; Belley-Cote E; Heels-Ansdell D; Brignardello-Petersen R; Alquraini M; Perner A; Møller MH; Krag M; Almenawer S; Rochwerg B; Dionne J; Jaeschke R; Alshahrani M; Deane A; Perri D; Thebane L; Al-Omari A; Finfer S; Cook D; Guyatt G, 2018, 'Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials (Intensive Care Medicine, (2018), 44, 1, (1-11), 10.1007/s00134-017-5005-8)', Intensive Care Medicine, 44, pp. 277 - 278, http://dx.doi.org/10.1007/s00134-017-5023-6

Shetty A; Macdonald SPJ; Keijzers G; Williams JM; Tang B; de Groot B; Thompson K; Fraser JF; Finfer S; Bellomo R; Iredell J, 2018, 'Review article: Sepsis in the emergency department – Part 2: Investigations and monitoring', EMA - Emergency Medicine Australasia, 30, pp. 4 - 12, http://dx.doi.org/10.1111/1742-6723.12924

Alhazzani W; Alshamsi F; Belley-Cote E; Heels-Ansdell D; Brignardello-Petersen R; Alquraini M; Perner A; Møller MH; Krag M; Almenawer S; Rochwerg B; Dionne J; Jaeschke R; Alshahrani M; Deane A; Perri D; Thebane L; Al-Omari A; Finfer S; Cook D; Guyatt G, 2018, 'Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials', Intensive Care Medicine, 44, http://dx.doi.org/10.1007/s00134-017-5005-8

Young PJ; Mackle DM; Bailey MJ; Beasley RW; Bennett V; Deane AM; Eastwood GM; Finfer S; Freebairn RC; Litton E; Linke N; McArthur CJ; McGuinness SP; Panwar R; Bellomo R, 2017, 'Intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX): results of the pilot phase', Critical Care and Resuscitation, 19, pp. 344 - 354, http://dx.doi.org/10.1016/S1441-2772(23)00959-6

Shetty A; MacDonald SPJ; Williams JM; van Bockxmeer J; de Groot B; Esteve Cuevas LM; Ansems A; Green M; Thompson K; Lander H; Greenslade J; Finfer S; Iredell J, 2017, 'Lactate ≥2 mmol/L plus qSOFA improves utility over qSOFA alone in emergency department patients presenting with suspected sepsis', EMA - Emergency Medicine Australasia, 29, pp. 626 - 634, http://dx.doi.org/10.1111/1742-6723.12894

Macdonald SPJ; Williams JM; Shetty A; Bellomo R; Finfer S; Shapiro N; Keijzers G, 2017, 'Review article: Sepsis in the emergency department – Part 1: Definitions and outcomes', EMA - Emergency Medicine Australasia, 29, pp. 619 - 625, http://dx.doi.org/10.1111/1742-6723.12886

Kissoon N; Reinhart K; Daniels R; Machado MFR; Schachter RD; Finfer S, 2017, 'Sepsis in Children: Global Implications of the World Health Assembly Resolution on Sepsis', Pediatric Critical Care Medicine, 18, pp. e625 - e627, http://dx.doi.org/10.1097/PCC.0000000000001340

Rudd KE; Delaney A; Finfer S, 2017, 'Counting sepsis, an imprecise but improving science', JAMA - Journal of the American Medical Association, 318, pp. 1228 - 1229, http://dx.doi.org/10.1001/jama.2017.13697

Hammond NE; Bellomo R; Gallagher M; Gattas D; Glass P; Mackle D; Micallef S; Myburgh J; Saxena M; Taylor C; Young P; Finfer S, 2017, 'The plasma-lyte 148 v saline (PLUS) study protocol: A multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality', Critical Care and Resuscitation, 19, pp. 239 - 246

Back to profile page